Stay updated with breaking news from Ipsen Euronext. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver
PARIS, FRANCE, 2 May 2024 - Ipsen , a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024....
Press release Intended for international media and investor audiences only Ipsen delivers strong sales in the first...
Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaborationFollowing development candidate validation, Ipsen will assume responsibility...
Ipsen secures exclusive global rights for development and commercialization of STRO-003, an antibody-drug conjugate, completing the final stages of...